Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-11-09 Sale | 2020-11-12 6:30 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 39,391 | $91.79 | $3,615,680 | 4,807,997 (Indirect Direct) | View |
| 2020-11-02 Sale | 2020-11-04 8:53 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman | 40,000 | $90.59 | $3,623,600 | 4,887,388 (Indirect Direct) | View |
| 2020-09-23 Sale | 2020-09-25 7:00 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 25,535 | $99.73 | $2,546,625 | 4,788,606 (Indirect Direct) | View |
| 2020-09-16 Sale | 2020-09-18 6:25 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 40,000 | $101.58 | $4,063,200 | 4,814,141 (Indirect Direct) | View |
| 2020-09-09 Sale | 2020-09-11 9:21 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 40,000 | $102.73 | $4,109,200 | 4,854,141 (Indirect Direct) | View |
| 2020-04-29 Sale | 2020-05-01 8:13 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 40,000 | $74.13 | $2,965,000 | 7,097,928 (Indirect Direct) | View |
| 2020-04-22 Sale | 2020-04-24 4:16 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 40,000 | $67.65 | $2,706,000 | 7,137,928 (Indirect Direct) | View |
| 2020-04-16 Sale | 2020-04-20 6:30 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 20,000 | $62.47 | $1,249,400 | 7,177,928 (Indirect Direct) | View |
| 2020-04-13 Sale | 2020-04-15 9:04 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 35,869 | $62.49 | $2,241,616 | 7,197,928 (Indirect Direct) | View |
| 2020-04-08 Sale | 2020-04-10 7:13 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 61,078 | $61.4 | $3,750,475 | 7,233,797 (Indirect Direct) | View |
| 2020-04-06 Sale | 2020-04-08 9:17 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 42,576 | $60.59 | $2,579,575 | 7,294,875 (Indirect Direct) | View |
| 2020-02-26 Sale | 2020-02-28 8:01 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 23,456 | $57.97 | $1,359,849 | 7,423,205 (Indirect Direct) | View |
| 2020-02-20 Sale | 2020-02-24 8:00 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 23,318 | $64.9 | $1,513,338 | 7,365,990 (Indirect Direct) | View |
| 2020-02-14 Sale | 2020-02-19 9:00 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 20,000 | $63.9 | $1,278,000 | 7,409,673 (Indirect Direct) | View |
| 2020-02-11 Sale | 2020-02-13 6:30 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 20,000 | $62.9 | $1,258,000 | 7,447,779 (Indirect Direct) | View |
| 2020-02-05 Sale | 2020-02-07 6:31 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Executive Chairman 10% Owner | 60,000 | $60.9 | $3,654,088 | 7,287,423 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-12-03 Other | 2021-12-07 9:10 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Director | 3,500,008 | $0 | 4,843,413 (Indirect) | View |
| 2021-12-03 Other | 2021-12-07 9:09 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | El-Hibri Fuad Director | 124,999 | $0 | 212,696 (Indirect) | View |
| 2021-06-01 Option Award | 2021-06-02 7:33 pm | N/A 2031-06-01 | Aptevo Therapeutics Inc. | APVO | El-Hibri Fuad Director | 3,571 | $0 | 3,571 (Direct) | View |
| 2021-02-24 Option Award | 2021-02-26 7:22 pm | N/A 2031-02-23 | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman | 41,714 | $0 | 41,714 (Direct) | View |
| 2020-07-02 Option Award | 2021-02-17 9:00 pm | N/A 2030-07-02 | Aptevo Therapeutics Inc. | APVO | El-Hibri Fuad Director | 3,571 | $0 | 3,571 (Direct) | View |
| 2020-11-09 Exercise | 2020-11-12 6:30 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 39,391 | $26.45 | 4,807,997 (Direct) | View |
| 2020-11-09 Exercise | 2020-11-12 6:30 pm | N/A 2022-03-09 | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 39,391 | $0 | 4,807,997 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-04 8:53 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman | 40,000 | $26.45 | 4,887,388 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-04 8:53 pm | N/A 2022-03-09 | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman | 40,000 | $0 | 4,887,388 (Direct) | View |
| 2020-07-27 Disposition | 2020-07-29 9:18 pm | N/A 2026-08-03 | Aptevo Therapeutics Inc. | APVO | El-Hibri Fuad Director | 4,016 | $0 | 1,492 (Direct) | View |
| 2020-07-27 Option Award | 2020-07-29 9:18 pm | N/A 2030-07-26 | Aptevo Therapeutics Inc. | APVO | El-Hibri Fuad Director | 1,492 | $0 | 1,492 (Direct) | View |
| 2020-02-26 Tax Withholding | 2020-02-28 8:01 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 4,895 | $59.91 | 7,423,205 (Direct) | View |
| 2020-02-27 Tax Withholding | 2020-02-28 8:01 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 3,854 | $58.42 | 7,423,205 (Direct) | View |
| 2020-02-26 Exercise | 2020-02-28 8:01 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 16,223 | $0 | 7,423,205 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-27 9:22 pm | N/A 2027-02-24 | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 58,593 | $0 | 7,506,910 (Direct) | View |
| 2020-02-25 Exercise | 2020-02-27 9:22 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 6,010 | $0 | 7,506,910 (Direct) | View |
| 2020-02-20 Exercise | 2020-02-24 8:00 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 23,318 | $25.62 | 7,365,990 (Direct) | View |
| 2020-02-20 Exercise | 2020-02-24 8:00 pm | N/A 2021-03-10 | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 23,318 | $0 | 7,365,990 (Direct) | View |
| 2020-02-14 Exercise | 2020-02-19 9:00 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 20,000 | $25.62 | 7,409,673 (Direct) | View |
| 2020-02-14 Exercise | 2020-02-19 9:00 pm | N/A 2021-03-10 | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 20,000 | $0 | 7,409,673 (Direct) | View |
| 2020-02-05 Exercise(A) | 2020-02-13 6:33 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 40,000 | $25.62 | 1,803,974 (Direct) | View |
| 2020-02-05 Exercise(A) | 2020-02-13 6:33 pm | N/A 2021-03-10 | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 60,000 | $0 | 1,803,974 (Direct) | View |
| 2020-02-11 Exercise | 2020-02-13 6:30 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 20,000 | $25.62 | 7,447,779 (Direct) | View |
| 2020-02-11 Exercise | 2020-02-13 6:30 pm | N/A 2021-03-10 | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 20,000 | $0 | 7,447,779 (Direct) | View |